IL6 and neoplasm: Recent studies have confirmed that relevant fungal components (mycobiome) activate the IL-1β/IL-6/IL-23–Th17 axis via receptors such as Dectin-1/TLR2/4, thereby shaping a pro-tumour inflammatory microenvironment (Xu et al., 2025; Saftien et al., 2023).